Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid CancersLori J. Wirth, Maria E. Cabanillas, Eric J. Sherman et al.|New England Journal of Medicine|2020Cited by 766
Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity FilterTobias Åkerström, Peyman Björklund, Joakim Crona et al.|PLoS ONE|2012Cited by 184
Activating mutations in CTNNB1 in aldosterone producing adenomasTobias Åkerström, Peyman Björklund, Rajani Maharjan et al.|Scientific Reports|2016Cited by 172
The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns StudyFrancesca Tentori, F. K. Port, Justin M. Albert et al.|Nephrology Dialysis Transplantation|2008Cited by 151
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C. Shonka, Gregory W. Randolph, Brendan C. Stack et al.|Head & Neck|2022Cited by 110